Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Primo Brands Corporation Class A Common Stock (PRMB) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Primo Brands Corporation Class A Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Primo Brands Corporation Class A Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Primo Brands Corporation Class A Common Stock trades at $18.76 (market cap $6.84B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Primo Brands Corporation Class A Common Stock is far larger — about 3.8× Vir Biotechnology Inc. Common Stock's market cap, and Primo Brands Corporation Class A Common Stock pays a 2.54% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Primo Brands Corporation Class A Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PRMBVIR
Market Cap
$6.84B$1.80B
Volume
2,864,5941,782,836
Sector
Consumer StaplesHealth
52-Week High
$25.39$11.78
52-Week Low
$14.46$5.12
Typical Hold Time
0 Days0 Days
Enterprise Value
$12.17B$1.36B
Dividend Yield
2.54%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Primo Brands Corporation Class A Common Stock

PRMB trades at $18.9, down 1.46% on the day, with a neutral technical signal and key support/resistance clustered around $19. The company reported Q2 2026 EPS of $0.37, beating expectations, and shows improving revenue and net income trends for 2026. Recent news highlights expansion with a new factory opening and strong premium water sales growth, supporting a positive analyst consensus.

The outlook is positive, driven by sales momentum and capacity expansion, but risks include thin net margins and high P/E ratio. With 80% of analysts rating it Buy and a consensus price target of $28.50, the stock offers significant upside potential if execution continues, though margin pressure remains a key watchpoint.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PRMB
100% Buy0% Sell
Avg holding period · 0 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Primo Brands Corporation Class A Common Stock

Primo Brands Corporation is a branded beverage company that produces and distributes packaged and purified water, water dispensers, and filtration equipment across North America, under brands including Poland Spring, Pure Life, Arrowhead, and Primo Water.

Read more on PRMB →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →